Jane Street
MBOT icon

Jane Street’s Microbot Medical MBOT Stock Holding History

Jane Street’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40K Buy
16,600
+5,300
+47% +$11.8K ﹤0.01% 11039
2025
Q4 		$22.6K Sell
11,300
-5,200
-32% -$12.3K ﹤0.01% 10700
2025
Q3 		$50.3K Buy
+16,500
New +$51.5K ﹤0.01% 10351

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Jane Street's MBOT Position: Q1 2026 in Review

Jane Street reduced its Microbot Medical (MBOT) stake by 28% in Q1 2026, selling an estimated $125K and leaving 141,541 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #8940.

Jane Street first reported a position in MBOT in Q1 2014 and has held it in 7 quarters since. The position peaked at $591K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Jane Street held 141,541 shares of Microbot Medical worth $341K as of Q1 2026.
  • Jane Street sold 55,867 Microbot Medical shares in Q1 2026, an estimated $125K.
  • Microbot Medical made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8940 holding.
  • Jane Street first reported a position in Microbot Medical in Q1 2014 and has held it in 7 quarters since.
  • Jane Street's Microbot Medical position peaked at $591K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.